Immediate effects of propofol on mood: a randomized comparison of two doses in a cohort with depression.
Anesthetic
Antidepressant
Depression
Mood
Propofol
Journal
Psychopharmacology
ISSN: 1432-2072
Titre abrégé: Psychopharmacology (Berl)
Pays: Germany
ID NLM: 7608025
Informations de publication
Date de publication:
17 Oct 2024
17 Oct 2024
Historique:
received:
03
04
2024
accepted:
02
10
2024
medline:
17
10
2024
pubmed:
17
10
2024
entrez:
17
10
2024
Statut:
aheadofprint
Résumé
The intravenous anesthetic propofol is known to induce positive mood effects during routine clinical use, suggesting it might be repurposed as an antidepressant, but also raising concerns about abuse potential. How propofol's acute effects vary by dose and with repeated infusions is unknown. This exploratory analysis aimed to (1) compare the immediate mood effects of propofol administered at two different doses, (2) describe how those mood effects change with repeated infusions, and (3) evaluate whether acute mood improvement predicts later antidepressant response. Twenty-four adults with moderate-to-severe treatment-resistant depression were randomized into two dosing groups. Six low- or high-dose propofol infusions were administered under blinded conditions over a two-week period. Self-reported mood states were recorded before and after each infusion using the Positive and Negative Affect Schedule (PANAS-X). Abuse potential was evaluated with the Drug Effects Questionnaire (DEQ-5). At the first infusion, propofol induced acute improvements in PANAS-X Sadness, Fear, Joviality, and Serenity scales (p < 0.002), independent of dose. Over the series of six infusions, acute changes in Sadness, Fear, and Joviality, but not Serenity, diminished with infusion number (p < 0.002). The DEQ-5 "want more" rating decreased across infusions (p = 0.002). Changes in PANAS-X scales with the first infusion did not predict later improvement in depression severity (p > 0.05). Cumulative changes in mood states observed with repeated infusions suggest that propofol engages adaptive mechanisms in mood circuitry. Subjective responses with repeated infusions do not indicate increasing potential for abuse in this patient population.
Identifiants
pubmed: 39417860
doi: 10.1007/s00213-024-06699-2
pii: 10.1007/s00213-024-06699-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCATS NIH HHS
ID : UL1TR002538
Pays : United States
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Aksoy M, Bozkurt M, Sayıt E, Unlü S, Karadag H (2013) Does spinal anesthesia increase the pain and anxiety after total knee arthroplasty? a randomized prospective study. Eklem Hastalıkları ve Cerrahisi = Joint Dis Relat Surg 24:30–32
doi: 10.5606/ehc.2013.07
Allain F, Minogianis E-A, Roberts DCS, Samaha A-N (2015) How fast and how often: The pharmacokinetics of drug use are decisive in addiction. Neurosci Biobehav Rev 56:166–179. https://doi.org/10.1016/j.neubiorev.2015.06.012
doi: 10.1016/j.neubiorev.2015.06.012
Baker SA, Benz CA, Dalton NA, Smith JJ, Stillmunkes AN, Elliott BA, Thompson ES (2000) Aninvestigation of the effect of 2 sedation regimens on patient mood state following upper extremity surgery using local anesthesia. AANA J 68(2):135–40
Bates D, Mächler M, Bolker B, Walker S (2014) Fitting Linear Mixed-Effects Models Using lme4. ArXiv E-Prints, arXiv:1406. https://doi.org/10.18637/jss.v067.i01
Birkenhager TK, Roos J, Kamperman AM (2019) Improvement after two sessions of electroconvulsive therapy predicts final remission in in-patients with major depression. Acta Psychiatr Scand 140(3):189–195. https://doi.org/10.1111/acps.13054
doi: 10.1111/acps.13054
pmcid: 6771780
Bleijenberg G, Buitelaar JK, van der Meer JWM (2010) The effect of ondansetron, a 5-HT3 receptor antagonist, in chronic fatigue syndrome: a randomized controlled trial. J Clin Pychiatr 71(5):5647. https://doi.org/10.4088/JCP.08m04719whi
doi: 10.4088/JCP.08m04719whi
Brechmann T, Maier C, Kaisler M, Vollert J, Schmiegel W, Pak S, Scherbaum N, Rist F, Riphaus A (2018) Propofol sedation during gastrointestinal endoscopy arouses euphoria in a large subset of patients. United Eur Gastroenterol J 6(4):536–546. https://doi.org/10.1177/2050640617736231
doi: 10.1177/2050640617736231
Brown EN, Pavone KJ, Naranjo M (2018) Multimodal general anesthesia: theory and practice. Anesth Analg 127(5):1246–1258. https://doi.org/10.1213/ANE.0000000000003668
doi: 10.1213/ANE.0000000000003668
pmcid: 6203428
Busto U, Sellers EM (1986) Pharmacokinetic determinants of drug abuse and dependence. A conceptual perspective. Clin Pharm 11(2):144–153. https://doi.org/10.2165/00003088-198611020-00004
doi: 10.2165/00003088-198611020-00004
Clark LA, Watson D (1994) The PANAS-X: Manual for the Positive and Negative Affect Schedule - Expanded Form. University of Iowa. https://doi.org/10.17077/48vt-m4t2
D’Haese J, Camu F, Dekeyzer PJ, D’Haenen HA (1994) Propofol and methohexitone anaesthesia: effects on the profile of mood state. Eur J Anaesthesiol 11(5):359–363
Davison LA, Steinhelber JC, Eger EI, Stevens WC (1975) Psychological effects of halothane and isoflurane anesthesia. Anesthesiology 43(3):313–324. https://doi.org/10.1097/00000542-197509000-00008
doi: 10.1097/00000542-197509000-00008
Earley PH, Finver T (2013) Addiction to propofol: a study of 22 treatment cases. J Addict Med 7(3):169–176. https://doi.org/10.1097/ADM.0b013e3182872901
doi: 10.1097/ADM.0b013e3182872901
Eleveld DJ, Colin P, Absalom AR, Struys MMRF (2018) Pharmacokinetic-pharmacodynamic model for propofol for broad application in anaesthesia and sedation. Br J Anaesth 120(5):942–959. https://doi.org/10.1016/j.bja.2018.01.018
doi: 10.1016/j.bja.2018.01.018
Fry RA, Fry LE, Castanelli DJ (2015) A retrospective survey of substance abuse in anaesthetists in Australia and New Zealand from 2004 to 2013. Anaesth Intensive Care 43(1):111–117. https://doi.org/10.1177/0310057X1504300117
doi: 10.1177/0310057X1504300117
Gupta A, Kullander M, Ekberg K, Lennmarken C (1995) Assessment of recovery following day-case arthroscopy. A comparison between propofol and isoflurane-based anaesthesia. Anaesthesia 50(11):937–942. https://doi.org/10.1111/j.1365-2044.1995.tb05923.x
doi: 10.1111/j.1365-2044.1995.tb05923.x
Gupta A, Kullander M, Ekberg K, Lennmarken C (1996) Anaesthesia for day-care arthroscopy. A comparison between desflurane and isoflurane. Anaesthesia 51(1):56–62. https://doi.org/10.1111/j.1365-2044.1996.tb07655.x
doi: 10.1111/j.1365-2044.1996.tb07655.x
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377–381. https://doi.org/10.1016/j.jbi.2008.08.010
doi: 10.1016/j.jbi.2008.08.010
pubmed: 18929686
Hofer CK, Zollinger A, Büchi S, Klaghofer R, Serafino D, Bühlmann S, Buddeberg C, Pasch T, Spahn DR (2003) Patient well-being after general anaesthesia: a prospective, randomized, controlled multi-centre trial comparing intravenous and inhalation anaesthesia. Br J Anaesth 91(5):631–637. https://doi.org/10.1093/bja/aeg243
doi: 10.1093/bja/aeg243
Iwama H, Obara S, Ozawa S, Furuta S, Ohmizo H, Watanabe K, Kaneko T (2003) Asurvey of combined epidural-propofol anesthesia with noninvasive positive pressure ventilation as a minimally invasive anesthetic protocol. Med Sci Monit: Int Med J Exp Clin Res 9(7):316–323
Johnson BA, Ait-Daoud N, Ma JZ, Wang Y (2003) Ondansetron reduces mood disturbance among biologically predisposed, alcohol-dependent individuals. Alcoholism Clin Exp Res 27(11):1773–1779. https://doi.org/10.1097/01.ALC.0000095635.46911.5D
doi: 10.1097/01.ALC.0000095635.46911.5D
Kalman SH, Jensen AG, Ekberg K, Eintrei C (1993) Early and late recovery after major abdominal surgery. Comparison between propofol anaesthesia with and without nitrous oxide and isoflurane anaesthesia. Acta Anaesthesiol Scand 37(8):730–736. https://doi.org/10.1111/j.1399-6576.1993.tb03799.x
doi: 10.1111/j.1399-6576.1993.tb03799.x
Kotani Y, Shimazawa M, Yoshimura S, Iwama T, Hara H (2008) The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neurosci Ther 14(2):95–106. https://doi.org/10.1111/j.1527-3458.2008.00043.x
doi: 10.1111/j.1527-3458.2008.00043.x
pmcid: 6494023
Kroenke K, Spitzer RL, Williams JBW (2001) The PHQ-9. J Gen Intern Med 16(9):606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
doi: 10.1046/j.1525-1497.2001.016009606.x
pubmed: 11556941
pmcid: 1495268
Kudoh A, Takahira Y, Katagai H, Takazawa T (2002) Small-dose ketamine improves the postoperative State of depressed patients. Anesth Analg 95(1):114–118. https://doi.org/10.1097/00000539-200207000-00020 . (table of contents)
doi: 10.1097/00000539-200207000-00020
Lamperti M (2015) Adult procedural sedation: an update. Curr Opin Anaesthesiol 28(6):662–667. https://doi.org/10.1097/ACO.0000000000000244
doi: 10.1097/ACO.0000000000000244
Lin C-H, Chen M-C, Yang W-C, Lane H-Y (2016) Early improvement predicts outcome of major depressive patients treated with electroconvulsive therapy. Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol 26(2):225–233. https://doi.org/10.1016/j.euroneuro.2015.12.019
doi: 10.1016/j.euroneuro.2015.12.019
Lipsitz O, McIntyre RS, Rodrigues NB, Kaster TS, Cha DS, Brietzke E, Gill H, Nasri F, Lin K, Subramaniapillai M, Kratiuk K, Teopiz K, Lui LMW, Lee Y, Ho R, Shekotikhina M, Mansur RB, Rosenblat JD (2021) Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of Excellence. Prog Neuropsychopharmacol Biol Psychiatry 105:110126. https://doi.org/10.1016/j.pnpbp.2020.110126
doi: 10.1016/j.pnpbp.2020.110126
Lutz P-E, Kieffer BL (2013) Opioid receptors: distinct roles in mood disorders. Trends Neurosci 36(3):195–206. https://doi.org/10.1016/j.tins.2012.11.002
doi: 10.1016/j.tins.2012.11.002
Lybbert C, Huang J, Jones KG, Mickey BJ, Tadler S, Odell D, Stanford J, Kuck K (2023) Clinical validation of an adapted Eleveld Model for high-dose propofol treatments for depression. J Clin Monit Comput 1–9. https://doi.org/10.1007/s10877-023-00986-7
Mathew RJ, Wilson WH (1991) Evaluation of the effects of diazepam and an experimental anti-anxiety drug on regional cerebral blood flow. Psychiatr Res: Neuroimaging 40(2):125–134. https://doi.org/10.1016/0925-4927(91)90004-A
doi: 10.1016/0925-4927(91)90004-A
Mcdonald NJ, Mannion D, Lee P, O’toole DP, O’boyle C, Keane PK (1988) Mood evaluation and outpatient anaesthesia. Anaesthesia 43(s1):68–69. https://doi.org/10.1111/j.1365-2044.1988.tb09075.x
doi: 10.1111/j.1365-2044.1988.tb09075.x
Mickey BJ, White AT, Arp AM, Leonardi K, Torres MM, Larson AL, Odell DH, Whittingham SA, Beck MM, Jessop JE, Sakata DJ, Bushnell LA, Pierson MD, Solzbacher D, Kendrick EJ, Weeks HR, Light AR, Light KC, Tadler SC (2018) Propofol for treatment-resistant depression: a pilot study. Int J Neuropsychopharmacol 21(12):1079–1089. https://doi.org/10.1093/ijnp/pyy085
doi: 10.1093/ijnp/pyy085
pmcid: 6276046
Morean ME, de Wit H, King AC, Sofuoglu M, Rueger SY, O’Malley SS (2013) The drug effects questionnaire: psychometric support across three drug types. Psychopharmacology 227(1):177–192. https://doi.org/10.1007/s00213-012-2954-z
doi: 10.1007/s00213-012-2954-z
Mortero RF, Clark LD, Tolan MM, Metz RJ, Tsueda K, Sheppard RA (2001) The effects of small-dose ketamine on propofol sedation: respiration, postoperative mood, perception, cognition, and pain. Anesth Analg 92(6):1465–1469. https://doi.org/10.1097/00000539-200106000-00022
doi: 10.1097/00000539-200106000-00022
Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, aan het Rot M, Collins KA, Mathew SJ, Charney DS, Iosifescu DV (2013) Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatr 74(4):250–256. https://doi.org/10.1016/j.biopsych.2012.06.022
doi: 10.1016/j.biopsych.2012.06.022
Nagata I, Sasaki M, Miyazaki T, Saeki K, Ogawa K-I, Kamiya Y (2022) Subanesthetic dose of propofol activates the reward system in rats. Anesth Analg 135(2):414–426. https://doi.org/10.1213/ANE.0000000000005847
doi: 10.1213/ANE.0000000000005847
Nagele P, Zorumski CF, Conway C (2018) Exploring Nitrous Oxide as Treatment of Mood Disorders: Basic Concepts. J Clin Psychopharmacol 38(2):144–148. https://doi.org/10.1097/JCP.0000000000000837
doi: 10.1097/JCP.0000000000000837
pmcid: 5825282
Oxorn D, Orser B, Ferris LE, Harrington E (1994) Propofol and thiopental anesthesia: a comparison of the incidence of dreams and perioperative mood alterations. Anesth Analg 79(3):553–557. https://doi.org/10.1213/00000539-199409000-00026
doi: 10.1213/00000539-199409000-00026
Pain L, Gobaille S, Schleef C, Aunis D, Oberling P (2002) In vivo dopamine measurements in the nucleus accumbens after nonanesthetic and anesthetic doses of propofol in rats. Anesth Analg 95(4):915–919. https://doi.org/10.1097/00000539-200210000-00022 . (table of contents)
doi: 10.1097/00000539-200210000-00022
Pollard BJ, Bryan A, Bennett D, Faragher EB, Un EN, Keegan M, Wilson A, Burkill M, Beatty PC, Stollery BT (1994) Recovery after oral surgery with halothane, enflurane, isoflurane or propofol anaesthesia. Br J Anaesth 72(5):559–566. https://doi.org/10.1093/bja/72.5.559
doi: 10.1093/bja/72.5.559
Pratila MG, Fischer ME, Alagesan R, Alagesan R, Reinsel RA, Pratilas D (1993) Propofol versus midazolam for monitored sedation: a comparison of intraoperative and recovery parameters. J Clin Anesth 5(4):268–274. https://doi.org/10.1016/0952-8180(93)90117-w
doi: 10.1016/0952-8180(93)90117-w
Ravussin P, de Tribolet N (1993) Total intravenous anesthesia with propofol for burst suppression in cerebral aneurysm surgery: preliminary report of 42 patients. Neurosurgery 32(2):236–240. https://doi.org/10.1227/00006123-199302000-00013 . (discussion 240)
doi: 10.1227/00006123-199302000-00013
Rosow CE (1997) Anesthetic drug interaction: an overview. J Clin Anesth 9(6 Suppl):27S-32S. https://doi.org/10.1016/s0952-8180(97)00124-4
doi: 10.1016/s0952-8180(97)00124-4
Rudkin GE, Osborne GA, Finn BP, Jarvis DA, Vickers D (1992) Intra-operative patient-controlled sedation. Anaesthesia 47(5):376–381. https://doi.org/10.1111/j.1365-2044.1992.tb02216.x
doi: 10.1111/j.1365-2044.1992.tb02216.x
Schnider TW, Minto CF, Gambus PL, Andresen C, Goodale DB, Shafer SL, Youngs EJ (1998) The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 88(5):1170–1182. https://doi.org/10.1097/00000542-199805000-00006
doi: 10.1097/00000542-199805000-00006
Serafini G, Howland RH, Rovedi F, Girardi P, Amore M (2014) The role of ketamine in treatment-resistant depression: a systematic review. Curr Neuropharmacol 12(5):444–461. https://doi.org/10.2174/1570159X12666140619204251
doi: 10.2174/1570159X12666140619204251
pmcid: 4243034
Setlock MA, Palmisano BW, Berens RJ, Rosner DR, Troshynski TJ, Murray KJ (1996) Tolerance to propofol generally does not develop in pediatric patients undergoing radiation therapy. Anesthesiology 85(1):207–209. https://doi.org/10.1097/00000542-199607000-00026
doi: 10.1097/00000542-199607000-00026
Shaikh N, Tallman B, Wang Y, Deshpande G, Tripathi S (2021) Evaluation of the development of tolerance following frequent administration of propofol in children requiring successive sedation for separate procedures. J Pediatr Pharmacol Ther: JPPT 26(3):277–283. https://doi.org/10.5863/1551-6776-26.3.277
doi: 10.5863/1551-6776-26.3.277
pmcid: 8021242
Singh H, Poluha W, Cheung M, Choptain N, Baron KI, Taback SP (2008) Propofol for sedation during colonoscopy. Cochr Database Syst Rev 4:CD006268. https://doi.org/10.1002/14651858.CD006268.pub2
doi: 10.1002/14651858.CD006268.pub2
Tadler SC, Jones KG, Lybbert C, Huang JC, Jawish R, Solzbacher D, Kendrick EJ, Pierson MD, Weischedel K, Rana N, Jacobs R, Vonesh LC, Feldman DA, Larson C, Hoffman N, Jessop JE, Larson AL, Taylor NE, Odell DH, …, Mickey BJ (2023) Propofol for treatment resistant depression: A randomized controlled trial. medRxiv. https://doi.org/10.1101/2023.09.12.23294678
Thapar P, Zacny JP, Choi M, Apfelbaum JL (1995) Objective and subjective impairment from often-used sedative/analgesic combinations in ambulatory surgery, using alcohol as a benchmark. Anesth Analg 80(6):1092–1098. https://doi.org/10.1097/00000539-199506000-00005
doi: 10.1097/00000539-199506000-00005
Uhlig T, Hüppe M, Pestel G, Keck S (1997) A comparison of the effect of propofol in 3 subhypnotic doses within the framework of tumor chemotherapy. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie: AINS 32(11):665–671. https://doi.org/10.1055/s-2007-995133
doi: 10.1055/s-2007-995133
Weisberg S, Fox J (2011) An R Companion to Applied Regression. Sage, Thousand Oaks
Whitehead C, Sanders LD, Oldroyd G, Haynes TK, Marshall RW, Rosen M, Robinson JO (1994) The subjective effects of low-dose propofol. A double-blind study to evaluate dimensions of sedation and consciousness with low-dose propofol. Anaesthesia 49(6):490–496. https://doi.org/10.1111/j.1365-2044.1994.tb03518.x
doi: 10.1111/j.1365-2044.1994.tb03518.x
Williams JB (1988) A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 45(8):742–747. https://doi.org/10.1001/archpsyc.1988.01800320058007
doi: 10.1001/archpsyc.1988.01800320058007
Xiong M, Shiwalkar N, Reddy K, Shin P, Bekker A (2018) Neurobiology of propofol addiction and supportive evidence: what is the new development? Brain Sci 8(2):36. https://doi.org/10.3390/brainsci8020036
doi: 10.3390/brainsci8020036
pmcid: 5836055
Ye JH, Ponnudurai R, Schaefer R (2006) Ondansetron: a selective 5-HT3 receptor antagonist and its applications in CNS-related disorders. CNS Drug Rev 7(2):199–213. https://doi.org/10.1111/j.1527-3458.2001.tb00195.x
doi: 10.1111/j.1527-3458.2001.tb00195.x
Zacny JP, Lichtor JL, Coalson DW, Finn RS, Uitvlugt AM, Glosten B, Flemming DC, Apfelbaum JL (1992) Subjective and psychomotor effects of subanesthetic doses of propofol in healthy volunteers. Anesthesiology 76(5):696–702. https://doi.org/10.1097/00000542-199205000-00006
doi: 10.1097/00000542-199205000-00006
Zacny JP, Lichtor JL, Zaragoza JG, Coalson DW, Uitvlugt AM, Flemming DC, Binstock WB, Cutter T, Apfelbaum JL (1993) Assessing the behavioral effects and abuse potential of propofol bolus injections in healthy volunteers. Drug Alcohol Depend 32(1):45–57. https://doi.org/10.1016/0376-8716(93)90021-h
doi: 10.1016/0376-8716(93)90021-h
Zhao K, Yang N, Yue J, Han Y, Wang X, Kang N, …, Xu M (2023) Factors associated with euphoria in large subset of cases using propofol sedation during gastrointestinal endoscopy. Front Psychiatr 14:1001626. https://doi.org/10.3389/fpsyt.2023.1001626